Publikationen in Zusammenarbeit mit Forschern von National Cancer Center Hospital (4)

2024

  1. Updated efficacy and safety of entrectinib in NTRK fusion-positive non-small cell lung cancer

    Lung Cancer, Vol. 188

2022

  1. Overcoming immunosuppression and pro-tumor inflammation in lung cancer with combined IL-1β and PD-1 inhibition

    Future Oncology, Vol. 18, Núm. 27, pp. 3085-3100

2021

  1. Amivantamab in egfr exon 20 insertion- mutated non-small-cell lung cancer progressing on platinum chemotherapy: Initial results from the chrysalis phase i study

    Journal of Clinical Oncology, Vol. 39, Núm. 30, pp. 3391-3402

  2. Canakinumab with and without pembrolizumab in patients with resectable non-small-cell lung cancer: CANOPY-N study design

    Future Oncology, Vol. 17, Núm. 12, pp. 1459-1472